Clinical trial
Esthesioneuroblastoma: Outcomes After Treatment
NCT02580136 is registered in ClinicalTrials.gov with Ricardo L. Carrau, MD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Esthesioneuroblastoma: Outcomes After Treatment
- Lead sponsor
- Ricardo L. Carrau, MD
- Phase
- Observational
- Overall status
- Withdrawn
- Start date
- September 30, 2015
- Completion date
- February 8, 2021
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.